# Official Journal C 392/2019

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 392 |
| | |
| English edition | Information and Notices | Volume 6219 November 2019 |

ISSN 1977-091X

Official Journal

of the European Union

C 392

English edition

Information and Notices

Volume 6219 November 2019

---

| Contents | page |
| --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2019/C 392/01 | Non-opposition to a notified concentration (Case M.9548 — Apollo Capital Management/Covivio/Hilton Kilmainham) (
  1
  ) | 1 |
| 2019/C 392/02 | Non-opposition to a notified concentration (Case M.9570 — Bridgepoint/Latour/Primonial) (
  1
  ) | 2 |
| 2019/C 392/03 | Non-opposition to a notified concentration (Case M.9509 — Warburg Pincus/CDPQ/Allied Universal) (
  1
  ) | 3 |

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2019/C 392/01

Non-opposition to a notified concentration (Case M.9548 — Apollo Capital Management/Covivio/Hilton Kilmainham) (
  1
  )

1

1

2019/C 392/02

Non-opposition to a notified concentration (Case M.9570 — Bridgepoint/Latour/Primonial) (
  1
  )

1

2

2019/C 392/03

Non-opposition to a notified concentration (Case M.9509 — Warburg Pincus/CDPQ/Allied Universal) (
  1
  )

1

3

---

| | IV   Notices |
| --- | --- |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | Council |
| 2019/C 392/04 | Notice for the attention of the persons subject to the restrictive measures provided for in Council Decision 2011/72/CFSP and Council Regulation (EU) No 101/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Tunisia | 4 |
| 2019/C 392/05 | Notice for the attention of the data subjects to whom the restrictive measures provided for in Council Decision 2011/72/CFSP and Council Regulation (EU) No 101/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Tunisia apply | 5 |
| | European Commission |
| 2019/C 392/06 | Euro exchange rates — 18 November 2019 | 6 |
| | Court of Auditors |
| 2019/C 392/07 | Special Report No 21/2019 Addressing antimicrobial resistance: progress in the animal sector, but this health threat remains a challenge for the EU | 7 |
| 2019/C 392/08 | Special Report No 24/2019 Asylum, relocation and return of migrants: Time to step up action to address disparities between objectives and results | 8 |

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

Council

2019/C 392/04

Notice for the attention of the persons subject to the restrictive measures provided for in Council Decision 2011/72/CFSP and Council Regulation (EU) No 101/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Tunisia

4

2019/C 392/05

Notice for the attention of the data subjects to whom the restrictive measures provided for in Council Decision 2011/72/CFSP and Council Regulation (EU) No 101/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Tunisia apply

5

European Commission

2019/C 392/06

Euro exchange rates — 18 November 2019

6

Court of Auditors

2019/C 392/07

Special Report No 21/2019 Addressing antimicrobial resistance: progress in the animal sector, but this health threat remains a challenge for the EU

7

2019/C 392/08

Special Report No 24/2019 Asylum, relocation and return of migrants: Time to step up action to address disparities between objectives and results

8

---

| | V   Announcements |
| --- | --- |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
| | European Commission |
| 2019/C 392/09 | Prior notification of a concentration (Case M.9639 — CDC/EDF/Dalkia Investissement) Candidate case for simplified procedure (
  1
  ) | 9 |
| 2019/C 392/10 | Prior notification of a concentration (Case M.9343 — Hyundai Heavy Industries/Daewoo Shipbuilding & Marine Engineering) (
  1
  ) | 11 |
| 2019/C 392/11 | Prior notification of a concentration (Case M.9461 — AbbVie/Allergan) (
  1
  ) | 12 |

V   Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

2019/C 392/09

Prior notification of a concentration (Case M.9639 — CDC/EDF/Dalkia Investissement) Candidate case for simplified procedure (
  1
  )

1

9

2019/C 392/10

Prior notification of a concentration (Case M.9343 — Hyundai Heavy Industries/Daewoo Shipbuilding & Marine Engineering) (
  1
  )

1

11

2019/C 392/11

Prior notification of a concentration (Case M.9461 — AbbVie/Allergan) (
  1
  )

1

12

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

1

| EN | |
| --- | --- |

EN

---

II Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 19.11.2019 | EN | Official Journal of the European Union | C 392/1 |
| --- | --- | --- | --- |

19.11.2019

EN

Official Journal of the European Union

C 392/1

---

Non-opposition to a notified concentration

(Case M.9548 — Apollo Capital Management/Covivio/Hilton Kilmainham)

(Text with EEA relevance)

(2019/C 392/01)

On 8 November 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9548. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9548. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 19.11.2019 | EN | Official Journal of the European Union | C 392/2 |
| --- | --- | --- | --- |

19.11.2019

EN

Official Journal of the European Union

C 392/2

---

Non-opposition to a notified concentration

(Case M.9570 — Bridgepoint/Latour/Primonial)

(Text with EEA relevance)

(2019/C 392/02)

On 11 November 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in French and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9570. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9570. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 19.11.2019 | EN | Official Journal of the European Union | C 392/3 |
| --- | --- | --- | --- |

19.11.2019

EN

Official Journal of the European Union

C 392/3

---

Non-opposition to a notified concentration

(Case M.9509 — Warburg Pincus/CDPQ/Allied Universal)

(Text with EEA relevance)

(2019/C 392/03)

On 11 November 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9509. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9509. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

Council

| 19.11.2019 | EN | Official Journal of the European Union | C 392/4 |
| --- | --- | --- | --- |

19.11.2019

EN

Official Journal of the European Union

C 392/4

---

Notice for the attention of the persons subject to the restrictive measures provided for in Council Decision 2011/72/CFSP and Council Regulation (EU) No 101/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Tunisia

(2019/C 392/04)

The following information is brought to the attention of the persons that appear in the Annex to Council Decision 2011/72/CFSP (1), and in Annex I to Council Regulation (EU) No 101/2011 (2), concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Tunisia.

The Council intends to renew the restrictive measures provided for in Decision 2011/72/CFSP. The Council holds on its file new elements concerning all persons listed in the Annex to Decision 2011/72/CFSP and in Annex I to Regulation (EU) No 101/2011.The persons concerned are hereby informed that they may submit a request to the Council to obtain the information that relates to them, before 25 November 2019, to the following address:

| Council of the European Union |
| --- |
| General Secretariat |
| RELEX.1.C |
| Rue de la Loi/Wetstraat 175 |
| 1048 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

Council of the European Union

General Secretariat

RELEX.1.C

Rue de la Loi/Wetstraat 175

1048 Bruxelles/Brussel

BELGIQUE/BELGIË

Email: sanctions@consilium.europa.eu

Any observations received will be taken into account for the purpose of the Council’s periodic review, in accordance with Article 5 of Decision 2011/72/CFSP and Article 12(4) of Regulation (EU) No 101/2011.

---

(1)  OJ L 28, 2.2.2011, p. 62.

(2)  OJ L 31, 5.2.2011, p. 1.

---

| 19.11.2019 | EN | Official Journal of the European Union | C 392/5 |
| --- | --- | --- | --- |

19.11.2019

EN

Official Journal of the European Union

C 392/5

---

Notice for the attention of the data subjects to whom the restrictive measures provided for in Council Decision 2011/72/CFSP and Council Regulation (EU) No 101/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Tunisia apply

(2019/C 392/05)

The attention of data subjects is drawn to the following information in accordance with Article 16 of Regulation (EU) 2018/1725 of the European Parliament and of the Council (1).

The legal basis for this processing operation are Council Decision (CFSP) 2011/72/CFSP (2) and Council Regulation (EU) No 101/2011 (3).

The controller of this processing operation is the Department RELEX.1.C in the Directorate-General for Foreign Affairs, Enlargement and Civil Protection — RELEX of the General Secretariat of the Council (GSC), that can be contacted at:

| Council of the European Union |
| --- |
| General Secretariat |
| RELEX.1.C |
| Rue de la Loi/Wetstraat 175 |
| 1048 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

Council of the European Union

General Secretariat

RELEX.1.C

Rue de la Loi/Wetstraat 175

1048 Bruxelles/Brussel

BELGIQUE/BELGIË

Email: sanctions@consilium.europa.eu

The GSC’s Data Protection Officer can be contacted at:

Data Protection Officer

data.protection@consilium.europa.eu

The purpose of the processing operation is the establishment and updating of the list of persons subject to restrictive measures in accordance with Decision (CFSP) 2011/72/CFSP and Regulation (EU) No 101/2011.

The data subjects are the natural persons who fulfil the listing criteria as laid down in Decision (CFSP) 2011/72/CFSP and Regulation (EU) No 101/2011.

The personal data collected includes data necessary for the correct identification of the person concerned, the statement of reasons and any other data related thereto.

The personal data collected may be shared as necessary with the European External Action Service and the Commission.

Without prejudice to restrictions pursuant to Article 25 of Regulation (EU) 2018/1725, the exercise of the rights of the data subjects such as the right of access, as well as the rights to rectification or to object will be answered in accordance with Regulation (EU) 2018/1725.

Personal data will be retained for 5 years from the moment the data subject has been removed from the list of persons subject to the restrictive measures or the validity of the measure has expired, or for the duration of court proceedings in the event they had been started.

Without prejudice to any judicial, administrative or non-judicial remedy, data subjects may lodge a complaint with the European Data Protection Supervisor in accordance with Regulation (EU) 2018/1725 (edps@edps.europa.eu).

---

(1)  OJ L 295, 21.11.2018, p. 39.

(2)  OJ L 28, 2.2.2011, p. 62.

(3)  OJ L 31, 5.2.2011, p. 1.

---

European Commission

| 19.11.2019 | EN | Official Journal of the European Union | C 392/6 |
| --- | --- | --- | --- |

19.11.2019

EN

Official Journal of the European Union

C 392/6

---

Euro exchange rates (1)

18 November 2019

(2019/C 392/06)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1061 |
| JPY | Japanese yen | 120,55 |
| DKK | Danish krone | 7,4726 |
| GBP | Pound sterling | 0,85330 |
| SEK | Swedish krona | 10,6603 |
| CHF | Swiss franc | 1,0960 |
| ISK | Iceland króna | 135,90 |
| NOK | Norwegian krone | 10,0860 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,593 |
| HUF | Hungarian forint | 335,27 |
| PLN | Polish zloty | 4,2915 |
| RON | Romanian leu | 4,7744 |
| TRY | Turkish lira | 6,3316 |
| AUD | Australian dollar | 1,6242 |
| CAD | Canadian dollar | 1,4622 |
| HKD | Hong Kong dollar | 8,6593 |
| NZD | New Zealand dollar | 1,7275 |
| SGD | Singapore dollar | 1,5047 |
| KRW | South Korean won | 1 289,14 |
| ZAR | South African rand | 16,3463 |
| CNY | Chinese yuan renminbi | 7,7629 |
| HRK | Croatian kuna | 7,4400 |
| IDR | Indonesian rupiah | 15 588,27 |
| MYR | Malaysian ringgit | 4,5964 |
| PHP | Philippine peso | 56,081 |
| RUB | Russian rouble | 70,6242 |
| THB | Thai baht | 33,443 |
| BRL | Brazilian real | 4,6201 |
| MXN | Mexican peso | 21,2907 |
| INR | Indian rupee | 79,4260 |

Currency

Exchange rate

USD

US dollar

1,1061

JPY

Japanese yen

120,55

DKK

Danish krone

7,4726

GBP

Pound sterling

0,85330

SEK

Swedish krona

10,6603

CHF

Swiss franc

1,0960

ISK

Iceland króna

135,90

NOK

Norwegian krone

10,0860

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,593

HUF

Hungarian forint

335,27

PLN

Polish zloty

4,2915

RON

Romanian leu

4,7744

TRY

Turkish lira

6,3316

AUD

Australian dollar

1,6242

CAD

Canadian dollar

1,4622

HKD

Hong Kong dollar

8,6593

NZD

New Zealand dollar

1,7275

SGD

Singapore dollar

1,5047

KRW

South Korean won

1 289,14

ZAR

South African rand

16,3463

CNY

Chinese yuan renminbi

7,7629

HRK

Croatian kuna

7,4400

IDR

Indonesian rupiah

15 588,27

MYR

Malaysian ringgit

4,5964

PHP

Philippine peso

56,081

RUB

Russian rouble

70,6242

THB

Thai baht

33,443

BRL

Brazilian real

4,6201

MXN

Mexican peso

21,2907

INR

Indian rupee

79,4260

---

(1)  Source: reference exchange rate published by the ECB.

---

Court of Auditors

| 19.11.2019 | EN | Official Journal of the European Union | C 392/7 |
| --- | --- | --- | --- |

19.11.2019

EN

Official Journal of the European Union

C 392/7

---

Special Report No 21/2019

‘Addressing antimicrobial resistance: progress in the animal sector, but this health threat remains a challenge for the EU’

(2019/C 392/07)

The European Court of Auditors hereby informs you that Special Report No 21/2019 ‘Addressing antimicrobial resistance: progress in the animal sector, but this health threat remains a challenge for the EU’ has just been published.

The report can be accessed for consultation or downloading on the European Court of Auditors’ website: http://eca.europa.eu

---

| 19.11.2019 | EN | Official Journal of the European Union | C 392/8 |
| --- | --- | --- | --- |

19.11.2019

EN

Official Journal of the European Union

C 392/8

---

Special Report No 24/2019

‘Asylum, relocation and return of migrants: Time to step up action to address disparities between objectives and results’

(2019/C 392/08)

The European Court of Auditors hereby informs you that Special Report No 24/2019 ‘Asylum, relocation and return of migrants: Time to step up action to address disparities between objectives and results’ has just been published.

The report can be accessed for consultation or downloading on the European Court of Auditors’ website: http://eca.europa.eu

---

V Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

| 19.11.2019 | EN | Official Journal of the European Union | C 392/9 |
| --- | --- | --- | --- |

19.11.2019

EN

Official Journal of the European Union

C 392/9

---

Prior notification of a concentration

(Case M.9639 — CDC/EDF/Dalkia Investissement)

Candidate case for simplified procedure

(Text with EEA relevance)

(2019/C 392/09)

1.

This notification concerns the following undertakings:

| — | Electricité de France (‘EDF’, France), |
| --- | --- |

—

Electricité de France (‘EDF’, France),

| — | Caisse des dépôts et consignations (‘CDC’, France), |
| --- | --- |

—

Caisse des dépôts et consignations (‘CDC’, France),

| — | Dalkia Investissement SAS (‘Dalkia Investissement’, France), controlled by EDF. |
| --- | --- |

—

Dalkia Investissement SAS (‘Dalkia Investissement’, France), controlled by EDF.

EDF and CDC acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Dalkia Investissement.

The concentration is accomplished by way of purchase of shares.

2.

| — | EDF and its subsidiaries are mainly active in the electricity sector, especially in the generation and wholesale of electricity, transportation and distribution of electricity in France and abroad. It is also active in the gas sector and in energy related services in France and abroad, |
| --- | --- |

—

EDF and its subsidiaries are mainly active in the electricity sector, especially in the generation and wholesale of electricity, transportation and distribution of electricity in France and abroad. It is also active in the gas sector and in energy related services in France and abroad,

| — | CDC is a French public institution with a special legal status, active in the management of private funds to which public authorities wish to provide special protection and in the financing of public-interest investment projects (transport, environment, transmission of electricity, etc.), |
| --- | --- |

—

CDC is a French public institution with a special legal status, active in the management of private funds to which public authorities wish to provide special protection and in the financing of public-interest investment projects (transport, environment, transmission of electricity, etc.),

| — | Dalkia Investissement is a holding company owning part of the shares of ELM SAS, which is responsible for the exploitation of the heat and cold networks of certain areas of the city of Lyon. |
| --- | --- |

—

Dalkia Investissement is a holding company owning part of the shares of ELM SAS, which is responsible for the exploitation of the heat and cold networks of certain areas of the city of Lyon.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

Case M.9639 — CDC/EDF/Dalkia Investissement

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---

| 19.11.2019 | EN | Official Journal of the European Union | C 392/11 |
| --- | --- | --- | --- |

19.11.2019

EN

Official Journal of the European Union

C 392/11

---

Prior notification of a concentration

(Case M.9343 — Hyundai Heavy Industries/Daewoo Shipbuilding & Marine Engineering)

(Text with EEA relevance)

(2019/C 392/10)

1.

This notification concerns the following undertakings:

| — | Hyundai Heavy Industries Co., Ltd. (‘HHI’) (Korea), |
| --- | --- |

—

Hyundai Heavy Industries Co., Ltd. (‘HHI’) (Korea),

| — | Daewoo Shipbuilding & Marine Engineering Co., Ltd. (‘DSME’) (Korea), controlled by the Korea Development Bank (‘KDB’). |
| --- | --- |

—

Daewoo Shipbuilding & Marine Engineering Co., Ltd. (‘DSME’) (Korea), controlled by the Korea Development Bank (‘KDB’).

HHI acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of DSME.

The concentration is accomplished by way of purchase of shares.

2.

| — | for HHI: a Korean company mainly active in the construction of commercial vessels, including oil tankers, containerships, liquefied natural gas (‘LNG’) carriers and liquefied petroleum gas (‘LPG’) carriers, military vessels, and offshore facilities and the production of marine engines, |
| --- | --- |

—

for HHI: a Korean company mainly active in the construction of commercial vessels, including oil tankers, containerships, liquefied natural gas (‘LNG’) carriers and liquefied petroleum gas (‘LPG’) carriers, military vessels, and offshore facilities and the production of marine engines,

| — | for DSME: a Korean company mainly active in the construction of commercial vessels including oil tankers, containerships, liquefied natural gas (‘LNG’) carriers and liquefied petroleum gas (‘LPG’) carriers and offshore facilities. |
| --- | --- |

—

for DSME: a Korean company mainly active in the construction of commercial vessels including oil tankers, containerships, liquefied natural gas (‘LNG’) carriers and liquefied petroleum gas (‘LPG’) carriers and offshore facilities.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9343 — Hyundai Heavy Industries/Daewoo Shipbuilding & Marine Engineering.

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---

| 19.11.2019 | EN | Official Journal of the European Union | C 392/12 |
| --- | --- | --- | --- |

19.11.2019

EN

Official Journal of the European Union

C 392/12

---

Prior notification of a concentration

(Case M.9461 — AbbVie/Allergan)

(Text with EEA relevance)

(2019/C 392/11)

1.

This notification concerns the following undertakings:

| — | AbbVie Inc., (‘AbbVie’, United States), |
| --- | --- |

—

AbbVie Inc., (‘AbbVie’, United States),

| — | Allergan plc (‘Allergan’, Ireland). |
| --- | --- |

—

Allergan plc (‘Allergan’, Ireland).

AbbVie acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Allergan.

The concentration is accomplished by way of purchase of shares.

2.

| — | AbbVie is a global pharmaceutical company listed on the New York Stock Exchange and headquartered in the United States. AbbVie is engaged in the development and commercialisation of innovative medicines in six main therapeutic areas: immunology (including autoimmune diseases), oncology, virology, neuroscience/central nervous system disorders, metabolic diseases and pain associated with endometriosis; |
| --- | --- |

—

AbbVie is a global pharmaceutical company listed on the New York Stock Exchange and headquartered in the United States. AbbVie is engaged in the development and commercialisation of innovative medicines in six main therapeutic areas: immunology (including autoimmune diseases), oncology, virology, neuroscience/central nervous system disorders, metabolic diseases and pain associated with endometriosis;

| — | Allergan is a global pharmaceutical company listed on the New York Stock Exchange and headquartered in Ireland. Allergan is engaged in the development and commercialisation of medicines in four key therapeutic areas: medical aesthetics, eye care, neuroscience/central nervous system disorders and gastroenterology. |
| --- | --- |

—

Allergan is a global pharmaceutical company listed on the New York Stock Exchange and headquartered in Ireland. Allergan is engaged in the development and commercialisation of medicines in four key therapeutic areas: medical aesthetics, eye care, neuroscience/central nervous system disorders and gastroenterology.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9461 — AbbVie/Allergan

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---